Prognostic Value of Myocardial CT-ECV in Severe Aortic Stenosis Requiring Aortic Valve Replacement: A Systematic Review and Meta-analysis

Computed tomography (CT)-derived extracellular volume fraction (ECV) is a non-invasive method to quantify myocardial fibrosis. Evaluating CT-ECV during aortic valve replacement (AVR) planning CT in severe aortic stenosis (AS) may aid prognostic stratification. This meta-analysis evaluated the progno...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal cardiovascular imaging 2025-01
Hauptverfasser: Faggiano, Andrea, Gherbesi, Elisa, Carugo, Stefano, Brusamolino, Matteo, Cozac, Dan Alexandru, Cozza, Elena, Savo, Maria Teresa, Cannata, Francesco, Guglielmo, Marco, La Mura, Lucia, Fazzari, Fabio, Carrabba, Nazario, Conte, Edoardo, Mushtaq, Saima, Baggiano, Andrea, Guaricci, Andrea I, Pedrinelli, Roberto, Indolfi, Ciro, Sinagra, Gianfranco, Perrone Filardi, Pasquale, Pergola, Valeria, Pontone, Gianluca
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Computed tomography (CT)-derived extracellular volume fraction (ECV) is a non-invasive method to quantify myocardial fibrosis. Evaluating CT-ECV during aortic valve replacement (AVR) planning CT in severe aortic stenosis (AS) may aid prognostic stratification. This meta-analysis evaluated the prognostic significance of CT-ECV in severe AS necessitating AVR. Electronic database searches of PubMed, OVID-MEDLINE, and Cochrane Library were performed. The primary outcome was to compare the occurrence of a composite of cardiovascular outcomes in patients with severe AS undergoing AVR with elevated myocardial CT-ECV values versus patients with normal values. Secondary outcomes included all-cause mortality and heart failure (HF) related hospitalization. A total of 1223 patients undergoing AVR for severe AS were included in 10 studies: 524 patients with high values of CT-ECV and 699 with normal values of CT-ECV. The pooled CT-ECV cut-off to define elevated values and predict prognosis was 30.7% (95% CI: 28.5-33.7%). At a mean follow-up of 17.9±2.3 months after AVR, patients with elevated CT-ECV experienced a significantly higher number of cardiovascular events (43.4% vs 14.0%; OR:4.3, 95% CI:3.192/5.764, p
ISSN:2047-2412
2047-2412
DOI:10.1093/ehjci/jeae324